Basel: Novartis sells part of the Klybeck development site Novartis Pharma is selling an approximately 160,000 sqm development site in Basel's Klybeck district to Central Real Estate Group. You need to be logged in to view this content. Please Log In. Not a Member? Join Us Annual subscription "IB+ Database" CHF 95.00 incl. VAT Add to cart
